Longevity Health Holdings Inc (XAGE) Directors and Executive Officers - CSIMarket
CSIMarket
 
Longevity Health Holdings Inc   (XAGE)

Longevity Health Holdings Inc

Officers & Directors


As of March 27, 2026, the executive officers are Janakiram Ajjarapu, age 57, serving as Chairman, Chief Executive Officer, and Class III Director, and Bryan Cassaday, age 57, serving as Chief Financial Officer. Bryan Cassaday previously served as Interim Chief Financial Officer from June 2023 to November 2023. He has over 30 years of experience in strategic financial leadership across multiple industries. Prior to joining the company, Cassaday was Controller for Nevakar, Inc. from 2021 to 2023, overseeing accounting, finance, financial reporting, and planning functions. He served as Chief Financial Officer of Atalian Global Services from 2019 to 2020, Acting Chief Financial Officer and Controller of EMCOR Facilities Services from 2015 to 2019, and Controller of SeeChange Health from 2013 to 2015. From 1993 to 2013, he held leadership roles at Nationwide Financial, Prevail InfoWorks, Delaware Investments, and Delphi Financial Group. He began his career as a senior auditor at Ernst & Young from 1990 to 1993. Cassaday holds a B.S. in Accounting from Drexel University and is a Certified Public Accountant and Chartered Global Management Accountant.

Longevity Health Holdings Inc currently has 10 employees.






XAGE Management Effectiveness XAGE Revenue per Employee XAGE Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.